EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Gayatri BioOrganics EBITDA Margin % Related Terms
Gayatri BioOrganics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Gayatri BioOrganics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Gayatri BioOrganics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gayatri BioOrganics EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Gayatri BioOrganics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Gayatri BioOrganics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gayatri BioOrganics (BOM:524564) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gayatri BioOrganics and its competitors. According to the industry distribution chart, Gayatri BioOrganics ranks #999999 out of 1579 companies in the Chemicals industry.
Is Gayatri BioOrganics' EBITDA Margin % too high?
Gayatri BioOrganics' current EBITDA Margin % is 0.00%. Based on the distribution chart, Gayatri BioOrganics ranks #999999 out of 1579 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Gayatri BioOrganics has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Gayatri BioOrganics' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Gayatri BioOrganics ranks #999999 out of 1579 companies for EBITDA Margin %. This places Gayatri BioOrganics in the lower half of its industry. The industry median EBITDA Margin % is 9.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,579 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Gayatri BioOrganics and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gayatri BioOrganics's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gayatri BioOrganics stock overvalued right now?
Gayatri BioOrganics (BOM:524564) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Gayatri BioOrganics' overall GF Score™ is 25/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Gayatri BioOrganics (BOM:524564), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gayatri BioOrganics Ltd is engaged in the manufacturing of starch, modified starches, liquid glucose, sorbitol, and its allied products, and trading in maize. Other products offered by the company include corn fiber, germ, gluten, Bio-oxide-G, Bio-theen-G, Bio-y-dext, and Bio-w-dext. It is one of the manufacturing units of Starch, Modified Starches ,Liquid Glucose, Sorbitol, and its allied products in south India with a wide distribution network across the country.
25GF Score
Get the complete analysis for BOM:524564
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524564 has been successfully added to your 
